Itzhak Nir, MD
Plastic and Reconstructive Surgery · Loxahatchee, FLNPI 1124015482
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (40.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by AbbVie at 45.5% of the total.
Across 192 payments — averaging $97.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Davol Inc.$6K
- TELA Bio, Inc.$2K
- Integra Lifesciences Corporation$892
- Mentor Worldwide LLC$680
- TEI Biosciences Inc$227
- plus $565 from 8 others
Across 7 payments — averaging $9637.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$67K
What the payments were for
- Speaking & faculty fees$5,85031%
- Food & beverage$4,68925%
- Gifts$7,45440%
- Other$6523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $8,488 |
| Davol Inc. | 2 | $5,915 |
| TELA Bio, Inc. | 67 | $1,878 |
| Integra Lifesciences Corporation | 14 | $892 |
| Mentor Worldwide LLC | 27 | $680 |
| TEI Biosciences Inc | 17 | $227 |
| Revance Therapeutics, Inc. | 3 | $220 |
| Johnson & Johnson | 1 | $122 |
| Sientra, Inc. | 6 | $111 |
| Merz North America, Inc. | 2 | $42 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $22 |
| Avanos Medical | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,644 in reported general payments places this provider in the 85th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 25 | $269 |
| Cephalexin | 25 | $159 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $146 |
| Methylprednisolone | 14 | $92 |
| Diazepam | 14 | $23 |
| Ondansetron Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Loxahatchee
- Alan DurkinVero Beach$548K
- Edgar SosaVero Beach$504K
- Vaishali DoolabhJacksonville$306K
- Sai Ramakrishna Velamuri VenkataTampa$303K
- Lee GibsteinBay Harbor Islands$216K
- John MurrayJacksonville$188K
- Arthur DesrosiersMiami$156K
- Miguel MedinaMiami$80K
- Roger KhouriCoconut Grove$80K
- George KamelFort Lauderdale$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.